---
title: "MYL: Subsidiary obtains drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254389837.md"
description: "MYL announced that its subsidiary Jiangxi MYL Meikang Pharmaceutical Co., Ltd. has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops issued by the National Medical Products Administration. Olopatadine Hydrochloride Eye Drops are used to treat eye itching associated with allergic conjunctivitis"
datetime: "2025-08-25T08:09:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254389837.md)
  - [en](https://longbridge.com/en/news/254389837.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254389837.md)
---

# MYL: Subsidiary obtains drug registration certificate

MYL announced that its subsidiary Jiangxi MYL Meikang Pharmaceutical Co., Ltd. has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops issued by the National Medical Products Administration. Olopatadine Hydrochloride Eye Drops are used to treat eye itching associated with allergic conjunctivitis

### Related Stocks

- [600993.CN](https://longbridge.com/en/quote/600993.CN.md)

## Related News & Research

- [The hidden bottlenecks that keep global trade alive](https://longbridge.com/en/news/293798613.md)
- [Clinton Foundation launches an institute to help state governments find nonpartisan solutions](https://longbridge.com/en/news/293929574.md)
- [Sam Altman said AI hasn't led to 4-hour workweeks because people are competitive](https://longbridge.com/en/news/293883472.md)
- [Rome Capital holds 51% stake in Acea, or 108,611,150 shares, filing shows](https://longbridge.com/en/news/294018301.md)
- [EXPLAINER-Why is Oman proposing a new plan to manage the Strait of Hormuz?](https://longbridge.com/en/news/294086547.md)